340 related articles for article (PubMed ID: 38279176)
1. 14-3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer.
Zhang Y; Yan M; Yu Y; Wang J; Jiao Y; Zheng M; Zhang S
Cell Commun Signal; 2024 Jan; 22(1):72. PubMed ID: 38279176
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic dissection of a native 14-3-3ε interacting protein complex associated with hepatocellular carcinoma.
Bai C; Tang S; Bai C; Chen X
Amino Acids; 2014 Apr; 46(4):841-52. PubMed ID: 24363202
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3ε mediates the cell fate decision-making pathways in response of hepatocellular carcinoma to Bleomycin-induced DNA damage.
Tang S; Bao H; Zhang Y; Yao J; Yang P; Chen X
PLoS One; 2013; 8(3):e55268. PubMed ID: 23472066
[TBL] [Abstract][Full Text] [Related]
4. Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
Oncotarget; 2015 Nov; 6(36):38967-82. PubMed ID: 26516929
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of focal adhesion kinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma.
Ko BS; Jan YJ; Chang TC; Liang SM; Chen SC; Liu TA; Wu YM; Wang J; Liou JY
Anticancer Agents Med Chem; 2013 May; 13(4):555-62. PubMed ID: 22934705
[TBL] [Abstract][Full Text] [Related]
6. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of 14-3-3ε predicts tumour metastasis and poor survival in hepatocellular carcinoma.
Ko BS; Chang TC; Hsu C; Chen YC; Shen TL; Chen SC; Wang J; Wu KK; Jan YJ; Liou JY
Histopathology; 2011 Apr; 58(5):705-11. PubMed ID: 21401702
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3ε boosts bleomycin-induced DNA damage response by inhibiting the drug-resistant activity of MVP.
Tang S; Bai C; Yang P; Chen X
J Proteome Res; 2013 Jun; 12(6):2511-24. PubMed ID: 23590642
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY
Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401
[TBL] [Abstract][Full Text] [Related]
10. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
[TBL] [Abstract][Full Text] [Related]
12. 14-3-3epsilon contributes to tumour suppression in laryngeal carcinoma by affecting apoptosis and invasion.
Che XH; Chen H; Xu ZM; Shang C; Sun KL; Fu WN
BMC Cancer; 2010 Jun; 10():306. PubMed ID: 20565895
[TBL] [Abstract][Full Text] [Related]
13. TIPE‑2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3‑kinase/AKT signaling pathway.
Wang L; Chen C; Feng S; Tian J
Mol Med Rep; 2018 May; 17(5):7017-7026. PubMed ID: 29568863
[TBL] [Abstract][Full Text] [Related]
14. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
[TBL] [Abstract][Full Text] [Related]
15. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
Li Y; Bai W; Zhang J
Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
[TBL] [Abstract][Full Text] [Related]
17. MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K-AKT-β-catenin pathways.
Xie L; Dai H; Li M; Yang W; Yu G; Wang X; Wang P; Liu W; Hu X; Zhao M
J Cell Mol Med; 2019 May; 23(5):3386-3401. PubMed ID: 30793486
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.
Li Z; Tang M; Ling B; Liu S; Zheng Y; Nie C; Yuan Z; Zhou L; Guo G; Tong A; Wei Y
J Mol Med (Berl); 2014 Mar; 92(3):291-303. PubMed ID: 24281831
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
[TBL] [Abstract][Full Text] [Related]
20. Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches.
Hashemi M; Nadafzadeh N; Imani MH; Rajabi R; Ziaolhagh S; Bayanzadeh SD; Norouzi R; Rafiei R; Koohpar ZK; Raei B; Zandieh MA; Salimimoghadam S; Entezari M; Taheriazam A; Alexiou A; Papadakis M; Tan SC
Cell Commun Signal; 2023 Feb; 21(1):32. PubMed ID: 36759819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
